Kura Oncology Inc (KURA): Next-Year EPS Estimate 25.10%
As of 2026-06-11, Kura Oncology Inc (KURA) has a next-year EPS growth estimate of 25.10%.
On 2026-06-03, analyst consensus for KURA's next-year EPS growth shifted from 25.49% to 25.10% — a negative change of 0.39 percentage points. The revised estimate has been sustained across 7 subsequent trading sessions. Current-year growth is projected at -11.50%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 25.10%
- EPS growth this year
- -11.50%
- EPS next quarter (est)
- -$0.90
- Last price
- $8.86
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-11 | 25.10% | -11.50% | -$0.90 | $8.86 |
| 2026-06-10 | 25.10% | -11.50% | -$0.90 | $8.68 |
| 2026-06-09 | 25.10% | -11.50% | -$0.90 | $8.81 |
| 2026-06-08 | 25.10% | -11.50% | -$0.90 | $8.56 |
| 2026-06-07 | 25.10% | -11.50% | -$0.90 | $8.74 |
| 2026-06-04 | 25.10% | -11.50% | -$0.90 | $8.77 |
| 2026-06-03 | 25.10% | -11.50% | -$0.90 | $8.65 |
| 2026-06-02 | 25.49% | -11.52% | -$0.90 | $8.97 |
| 2026-06-01 | 25.49% | -11.52% | -$0.90 | $9.03 |
| 2026-05-31 | 25.49% | -11.52% | -$0.90 | $10.20 |
| 2026-05-28 | 25.49% | -11.52% | -$0.90 | $9.97 |
| 2026-05-27 | 25.49% | -11.52% | -$0.90 | $10.24 |
| 2026-05-26 | 25.49% | -11.52% | -$0.90 | $10.41 |
| 2026-05-25 | 25.49% | -11.52% | -$0.90 | $11.25 |
| 2026-05-24 | 25.49% | -11.52% | -$0.90 | $11.25 |
| 2026-05-21 | 25.49% | -11.52% | -$0.90 | $11.13 |
| 2026-05-20 | 25.49% | -11.52% | -$0.90 | $10.34 |
| 2026-05-19 | 26.02% | -12.17% | -$0.91 | $8.96 |
| 2026-05-18 | 26.02% | -12.17% | -$0.91 | $9.20 |
| 2026-05-17 | 26.02% | -12.17% | -$0.91 | $9.22 |
| 2026-05-14 | 26.02% | -12.17% | -$0.91 | $9.74 |
| 2026-05-13 | 26.02% | -12.17% | -$0.91 | $9.24 |
| 2026-05-12 | 27.09% | -13.36% | -$0.83 | $9.68 |
| 2026-05-11 | 27.09% | -13.36% | -$0.83 | $9.51 |
| 2026-05-10 | 27.09% | -13.36% | -$0.83 | $9.42 |
| 2026-05-07 | 27.09% | -13.36% | -$0.83 | $9.32 |
| 2026-05-06 | 27.09% | -13.36% | -$0.83 | $9.56 |
| 2026-05-05 | 27.09% | -13.36% | -$0.83 | $9.29 |
| 2026-05-04 | 27.09% | -13.36% | -$0.83 | $9.25 |
| 2026-05-03 | 27.09% | -13.36% | -$0.83 | $8.77 |
Screen Performance
Aggregate stats across all 1781 tickers our top-EPS-revision screen has flagged over the past 71 days.
- Median return since detection
- +3.8%
- % of tickers in the green
- 58%
- Median return on winners
- +18.5%
- Large revisions captured
- 788
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Kura Oncology Inc's next-year EPS growth estimate?▾
As of 2026-06-11, Kura Oncology Inc (KURA) has a next-year EPS growth estimate of 25.10%, based on analyst consensus.
When was the latest EPS estimate revision for KURA?▾
The most recent revision occurred on 2026-06-03, when analysts adjusted the next-year EPS growth estimate from 25.49% to 25.10%.
What sector and industry does Kura Oncology Inc belong to?▾
Kura Oncology Inc operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. KURA appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Kura Oncology Inc (KURA) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports